Noncoding RNAs as Prognostic Biomarkers After Myocardial Infarction: A Scoping Review
Background Prognosis after myocardial infarction (MI) remains heterogeneous despite contemporary reperfusion and secondary prevention, and biomarkers that capture post‐MI recovery, treatment response, and long‐term risk are still limited. Noncoding RNAs have therefore attracted interest as biomarker...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Wiley
2026-09-01
|
| Cyfres: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.ahajournals.org/doi/10.1161/JAHA.126.050885 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|